Published in J Immunol on March 01, 1975
Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes. J Exp Med (1976) 4.63
Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1978) 2.94
Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules. J Exp Med (1981) 1.65
Factors influencing the autologous mixed lymphocyte reaction in rats: effect of xenogeneic serum protein. Immunology (1981) 0.81
T cell proliferation induced by anti-self-I-A-specific T cell hybridomas. Evidence of a T cell network. J Exp Med (1986) 0.79
Studies on the syngeneic mixed lymphocyte reaction. II. Decline in he syngeneic mixed lymphocyte reaction with age. Immunology (1982) 0.77
Stimulation of rat autologous mixed lymphocyte reaction with xenogeneic sera and their protein preparations. Immunology (1983) 0.75
Capacity to interact with T-cell replacing factor correlates with acquisition by B cells of murine differentiation antigen-1. Immunology (1979) 0.75
Studies on the syngeneic mixed lymphocyte reaction. I. The ontogeny of the syngeneic mixed lymphocyte reaction in mice. Immunology (1982) 0.75
Isogeneic lymphocyte interaction: recognition of self antigens by cells of the neonatal thymus. Proc Natl Acad Sci U S A (1970) 1.78
The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol (1998) 1.72
Dual immunological unresponsiveness induced by cell membrane coupled hapten or antigen. Nature (1966) 1.68
Influence of thymosin on cell-mediated and humoral immune responses in normal and in immunologically deficient mice. J Immunol (1970) 1.62
Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization. Dig Dis Sci (1979) 1.60
Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology (1984) 1.49
B cell lymphomas of C57L/J mice; the role of natural killer cells and T helper cells in lymphoma development and growth. Leuk Res (2000) 1.45
Splenic T-killer cells can be generated by allogeneic thymic cells in conjunction with assisting factor. Nature (1977) 1.32
Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin. J Immunol (1983) 1.25
Splenic determination of immunocompetence: influence on other lymphoid organs. Cell Immunol (1971) 1.23
Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2. J Immunol (1983) 1.12
Immunoglobulin synthesis in hereditarily spleenless mice. Nature (1969) 1.12
Mechanism of immunologic unresponsiveness: a new approach. Fed Proc (1990) 1.12
Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. J Biol Chem (1990) 1.09
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res (1999) 1.09
Spontaneous delayed iso-hypersensitivity in guinea pigs. J Immunol (1968) 1.08
Regulation of immunoglobulin synthesis by dextran. J Exp Med (1973) 1.07
Immunologic responses of guinea pigs to dextran. J Immunol (1968) 1.07
Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity. J Immunol (1985) 1.06
Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T cells and enhanced proliferation to Staphylococcus aureus and lipopolysaccharides. Dig Dis Sci (1981) 1.03
Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells. J Clin Invest (1999) 1.02
Placental mononuclear phagocytes as a source of interleukin-1. Science (1982) 0.97
Splenic replenishment of synergistic ability to bone marrow and thymic cells of neonatally splenectomized CBA mice. J Exp Med (1972) 0.97
Feeding trinitrochlorobenzene inhibits development of hapten-specific cytotoxic T lymphocytes by interfering with helper T-cell function. Reg Immunol (1990) 0.97
Susceptibility to adjuvant arthritis in DA and F344 rats. A dominant trait controlled by an autosomal gene locus linked to the major histocompatibility complex. Arthritis Rheum (1982) 0.95
Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma. J Natl Cancer Inst (1999) 0.94
Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res (1999) 0.93
Specific immunologic unresponsiveness induced in adult guinea pigs with the aid of p-azobenzenearsonate hapten coupled to autologous red cells. J Immunol (1971) 0.93
Properties of reticulum cell sarcomas in SJL/J mice. V. Nature of reticulum cell sarcoma surface antigen which induces proliferation of normal SJL/J T cells. J Exp Med (1977) 0.92
Caspase-dependent and -independent death pathways in cancer therapy. Apoptosis (2000) 0.92
Reticulum cell sarcomas of SJL mice have rearranged immunoglobulin heavy and light chain genes. Eur J Immunol (1989) 0.90
Impaired delayed hypersensitivity in germ-free guinea-pigs. Immunology (1970) 0.90
Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X. J Immunol (1988) 0.90
Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population. Cell Immunol (1990) 0.90
Mechanism of apoptosis induced by zinc deficiency in peripheral blood T lymphocytes. Apoptosis (2001) 0.90
Transfer of memory cells into antigen-pretreated hosts. I. Functional detection of migration sites for antigen-specific B cells. Cell Immunol (1977) 0.90
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy. Clin Cancer Res (1998) 0.88
Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma. J Immunother (1997) 0.88
Specificity of fixation loci for homocytotropic antibodies. J Exp Med (1971) 0.87
Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene (2012) 0.86
IFN-gamma and IL-2 cooperatively activate NF kappa B in murine peritoneal macrophages. J Immunol (1992) 0.86
Generation of alloreactive cytotoxic T lymphocytes: production of T cell and macrophage helper factors in addition to IL 1 and IL 2 by peritoneal cells from mice immunized to Listeria monocytogenes. J Immunol (1981) 0.86
Adoptive cutaneous anaphylaxis: a technique for studying antibody globulin synthesis. J Immunol (1966) 0.86
Reversal of phorbol ester-mediated reduction of cloned T lymphocyte cytolysis by interleukin 2. J Immunol (1985) 0.85
Soluble helper factor(s) participates in the generation of cell mediated cytotoxicity directed against syngeneic tumor cells. J Immunol (1979) 0.85
In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles. Inhal Toxicol (2013) 0.84
In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor. J Immunol (1983) 0.84
T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance. Crit Rev Immunol (2001) 0.84
Suppression of adjuvant arthritis by antibodies specific for collagen type II. Immunol Commun (1981) 0.84
Use of immunotolerance to dissect the mechanisms regulating appearance of hapten-specific killer T cells in vivo. J Immunol (1980) 0.84
Characterization of SJL T cell clones responsive to syngeneic lymphoma (RCS): RCS-specific clones are stimulated by activated B cells. J Immunol (1985) 0.84
Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape. Cancer J Sci Am (2000) 0.84
Natural killer cell activity in reticulum cell sarcomas (RCS) of SJL/J mice. Cell Immunol (1979) 0.84
Spontaneous production of T (type II) interferon by a murine reticulum-cell sarcoma. Ann N Y Acad Sci (1980) 0.83
Properties of transplantable reticulum cell sarcomas in SJL/J mice. Adv Exp Med Biol (1976) 0.83
Transfer of memory cells into antigen-pretreated hosts. II. Influence of localized antigen on the migration of specific memory B cells. Eur J Immunol (1981) 0.83
Graft-vs-host reactions in F1 mice induced by parental lymphoid cells: nature of recruited F1 cells. J Immunol (1976) 0.82
Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2. Am J Pathol (1994) 0.82
Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma. Int J Cancer (1993) 0.82
Long-term exposure of HL60 cells to 1,25-dihydroxyvitamin D3 reduces their tumorigenicity: a model for cancer chemoprevention. Proc Soc Exp Biol Med (1997) 0.81
Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-Hodgkin's lymphomas. Cancer Immunol Immunother (1995) 0.81
Lymphoid cell dependence of eosinophil response to antigen. 3. Comparison of the rate of appearance of two types of memory cells in various lymphoid tissues at different times after priming. J Immunol (1973) 0.81
Down-regulation of adoptive adjuvant-induced arthritis by suppressor factor(s). Arthritis Rheum (1991) 0.81
Natural killer cell activity in reticulum-cell sarcomas of SJL/J mice. III. Characterization of the effector cells within RCS that mediate NK lysis. Int J Cancer (1981) 0.81
Autologous and syngeneic mixed lymphocyte reactions and their immunological significance. Prog Allergy (1981) 0.81
Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor level. Cancer Res (1990) 0.80
Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. II. Rapid production of antibody-enhancing factor, interleukin 2, and immune interferon. J Natl Cancer Inst (1984) 0.80
Effects of cord blood transfer on the hematopoietic recovery following sublethal irradiation in MRL lpr/lpr mice. Proc Soc Exp Biol Med (1999) 0.80
Endogenous hematopoietic reconstitution induced by human umbilical cord blood cells in immunocompromised mice: implications for adoptive therapy. Exp Hematol (1999) 0.80
In vitro lymphocyte transformation induced by pre-existing hypersensitivity to foetal calf serum. Clin Exp Immunol (1971) 0.79
Induction by interleukin-2 of oligoclonal expansion of cultured tumor-infiltrating lymphocytes. J Natl Cancer Inst (1990) 0.79
Dextran augments delayed-type hypersensitivity by interrupting one limb of the suppressor cascade. J Immunol (1985) 0.79
META-controlled env-initiated transcripts encoding superantigens of murine Mtv29 and Mtv7 and their possible role in B cell lymphomagenesis. J Immunol (2001) 0.79
Dextran abrogates stimulation of IgG antibody synthesis by allogeneic effect factor. J Immunol (1977) 0.79
Effects of an antiserum to calf thymosin on lymphoid cells in vitro. Proc Soc Exp Biol Med (1969) 0.79
Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources. Cancer Immunol Immunother (1990) 0.79
The effect of human cord blood on SJL/J mice after chemoablation and irradiation and its possible clinical significance. Immunol Invest (1995) 0.79
Effect of antigen on localization of immunologically specific B cells. Adv Exp Med Biol (1976) 0.79
Murine survival of lethal irradiation with the use of human umbilical cord blood. Life Sci (1992) 0.79
Dextran induces changes in immunological responses to unrelated antigenic and haptenic stimuli. Immunology (1973) 0.78
Dextran's regulatory effect on immunoglobulin synthesis is mediated through T cells. Cell Immunol (1974) 0.78
H-2K/H-2D and Mls and I region-associated antigens stimulate helper factor(s) involved in the generation of cytotoxic T lymphocytes. J Immunol (1980) 0.78
Reverse immune surveillance: an adaptive mechanism used by tumor cells to facilitate their survival and growth. Semin Cancer Biol (2000) 0.78
Evaluation of the possible role of B cell receptors in the tendency of B cells to migrate into follicles in mice and chickens. Eur J Immunol (1977) 0.78
Comparison of interleukin 1 production by adherent cells and tissue pieces from human placenta. Immunopharmacology (1985) 0.78
Lymphocyte responses to syngeneic antigens. I. Enhancement of the murine autologous mixed lymphocyte response by polyethylene glycol. Cell Immunol (1980) 0.78
The feasibility of using blood bank-stored (4 degrees C) cord blood, unmatched for HLA for marrow transplantation. Am J Clin Pathol (1999) 0.78
IL-10 production in a CD5+ B cell lymphoma arising in a CD4 monoclonal antibody-treated SJL mouse. Clin Immunol Immunopathol (1992) 0.78
Unilateral localization of hapten-specific B memory cells in lymph node draining a footpad injection of antigen. Adv Exp Med Biol (1982) 0.78
The autologous mixed lymphocyte reaction is decreased in Freund's adjuvant-injected rats of arthritis-susceptible and -insusceptible strains. Arthritis Rheum (1985) 0.78
In vitro detection of spontaneously occurring delayed-type iso-hypersensitivity. Immunology (1971) 0.78
Restriction of tumor growth in mice by sodium-deficient diet. Cancer Res (1988) 0.78
Natural killer cell activity in reticulum-cell sarcomas of SJL/J mice. II. Analysis of RCS-associated NK activity. Int J Cancer (1981) 0.78
Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12. J Immunother (1999) 0.78
Tolerance to a defined chemical hapten produced in adult guinea-pigs after thymectomy. Immunology (1966) 0.77